A Review of Mathematical Models for Tumor Dynamics and Treatment Resistance Evolution of Solid Tumors
Anyue Yin,Dirk Jan A.R. Moes,Johan G.C. van Hasselt,Jesse J. Swen,Henk-Jan Guchelaar +4 more
- Vol. 8, Iss: 10, pp 720-737
TLDR
The opportunities of a model‐based approach as discussed in this review can be of great benefit for future optimizing and personalizing anticancer treatment.Abstract:
Increasing knowledge of intertumor heterogeneity, intratumor heterogeneity, and cancer evolution has improved the understanding of anticancer treatment resistance. A better characterization of cancer evolution and subsequent use of this knowledge for personalized treatment would increase the chance to overcome cancer treatment resistance. Model-based approaches may help achieve this goal. In this review, we comprehensively summarized mathematical models of tumor dynamics for solid tumors and of drug resistance evolution. Models displayed by ordinary differential equations, algebraic equations, and partial differential equations for characterizing tumor burden dynamics are introduced and discussed. As for tumor resistance evolution, stochastic and deterministic models are introduced and discussed. The results may facilitate a novel model-based analysis on anticancer treatment response and the occurrence of resistance, which incorporates both tumor dynamics and resistance evolution. The opportunities of a model-based approach as discussed in this review can be of great benefit for future optimizing and personalizing anticancer treatment.read more
Citations
More filters
Book ChapterDOI
The Mathematical Model
TL;DR: The death rate per tumor cell due to immunological response is proportional to the total number of antigen-producing (tumor) cells; thus, the total death rate is quadratic.
Journal ArticleDOI
Cancer modeling: From mechanistic to data-driven approaches, and from fundamental insights to clinical applications
TL;DR: A non-exhaustive overview of models according to their intrinsic features of in silico cancer models is provided, using the hallmarks of cancer as a guidance.
Journal ArticleDOI
Optimal control of cytotoxic and antiangiogenic therapies on prostate cancer growth
Pierluigi Colli,Hector Gomez,Guillermo Lorenzo,Guillermo Lorenzo,Gabriela Marinoschi,Alessandro Reali,Elisabetta Rocca +6 more
TL;DR: The results suggest that only cytotoxic chemotherapy is required to optimize therapeutic performance and it is shown that the optimal control framework can produce superior solutions to combined therapy with docetaxel and bevacizumab.
Journal ArticleDOI
Tumor Growth Dynamic Modeling in Oncology Drug Development and Regulatory Approval: Past, Present, and Future Opportunities.
TL;DR: This review is to comprehensively summarize the history of TGD, and present case examples of the recent advance ofTGD modeling (mixture model and joint model), as well as the TGD impact on regulatory decisions, thus illustrating challenges and opportunities.
Journal ArticleDOI
Treatment-driven tumour heterogeneity and drug resistance: Lessons from solid tumours.
Stefania Crucitta,Federico Cucchiara,Ron H.J. Mathijssen,Joaquin Mateo,Agnes Jager,Arjen Joosse,Antonio Passaro,Ilaria Attili,Iacopo Petrini,Ron H.N. van Schaik,Romano Danesi,Marzia Del Re +11 more
TL;DR: In this paper , the authors focused on tumour heterogeneity and its relation to resistance to targeted-therapy, based on treatment selective pressure across different tumour types, including lung, colorectal, prostate, breast cancer and melanoma.
References
More filters
Journal ArticleDOI
Computational oncology — mathematical modelling of drug regimens for precision medicine
Dominique Barbolosi,Joseph Ciccolini,Bruno Lacarelle,Fabrice Barlesi,Fabrice Barlesi,Nicolas André +5 more
TL;DR: The current achievements and limitations with regard to computational modelling of drug regimens are highlighted, and the potential future implementation of this strategy to achieve precision medicine in oncology is discussed.
Journal ArticleDOI
Quantitative Metrics of Net Proliferation and Invasion Link Biological Aggressiveness Assessed by MRI with Hypoxia Assessed by FMISO-PET in Newly Diagnosed Glioblastomas
Mindy D. Szeto,Gargi Chakraborty,Jennifer Hadley,Russell C. Rockne,Mark Muzi,Ellsworth C. Alvord,Kenneth A. Krohn,Alexander M. Spence,Kristin R. Swanson +8 more
TL;DR: This model has already been proven useful as a novel tool to dynamically quantify the net rates of proliferation (rho) and invasion (D) of the glioma cells in individual patients and can be calculated from routinely available pretreatment MRI in vivo.
Journal ArticleDOI
Clinically relevant modeling of tumor growth and treatment response.
Thomas E. Yankeelov,Nkiruka C. Atuegwu,David A. Hormuth,Jared A. Weis,Stephanie L. Barnes,Michael I. Miga,Erin C. Rericha,Vito Quaranta +7 more
TL;DR: In this article, the authors proposed the use of emerging, quantitative tumor imaging methods to initialize a new generation of predictive models, which could be able to forecast clinical outputs, such as overall response to treatment and time to progression, which will provide opportunities for guided intervention and improved patient care.
Journal ArticleDOI
A Review of Mixed-Effects Models of Tumor Growth and Effects of Anticancer Drug Treatment Used in Population Analysis
Benjamin Ribba,Nicholas H. G. Holford,Paolo Magni,Iñaki F. Trocóniz,Ivelina Gueorguieva,P Girard,C Sarr,M Elishmereni,Charlotte Kloft,Lena E. Friberg +9 more
TL;DR: This selection of models with published mathematical equations aimed at describing the dynamics of tumor size in cancer patients following anticancer drug treatment will constitute the basis for the Drug Disease Model Resources (DDMoRe) repository for models on oncology.
Journal ArticleDOI
Exploiting Evolution To Treat Drug Resistance: Combination Therapy and the Double Bind
TL;DR: A general evolutionary game theory framework of a double bind is presented to study the effect that such an approach would have in cancer and an explanation for its effectiveness based on the commensalistic relationship between the tumor phenotypes is provided.